"N Engl J Med"[journal] 检索结果

361. Progress in the Development of N-of-1 Therapy.

作者: Peter Marks.
来源: N Engl J Med. 2025年392卷22期2271-2272页

362. Alternative Complement Pathway, Iptacopan, and IgA Nephropathy. Reply.

作者: Jonathan Barratt.;Vlado Perkovic.;Dana V Rizk.
来源: N Engl J Med. 2025年392卷19期1976页

363. Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.

作者: Andrea Angeletti.;Maddalena Marasa.;Paolo Cravedi.
来源: N Engl J Med. 2025年392卷19期1976页

364. Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.

作者: Felix Poppelaars.;Bernardo Faria.;Joshua M Thurman.
来源: N Engl J Med. 2025年392卷19期1975页

365. Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD.

作者: Sofia K Mettler.;Pietro Nardelli.;Monica Iturrioz Campo.;Rubén San José Estépar.;Padma P Manapragada.;Mostafa Abozeed.;Muhammad Usman Aziz.;Mohd Zahid.;Scott Grumley.;Hrudaya P Nath.;Andrew Yen.;Sushilkumar Sonavane.;Christian F Clarenbach.;Wei Wang.;Carrie L Pistenmaa.;George R Washko.;Raúl San José Estépar.;Michael H Cho.;Alejandro A Diaz.; .; .
来源: N Engl J Med. 2025年392卷19期1973-1975页

366. Xenotransplantation - Long Awaited, Much Learned, Much More to Be Learned.

作者: Sandy Feng.
来源: N Engl J Med. 2025年392卷19期1971-1972页

367. Targeting Orexin Receptors to Treat Narcolepsy.

作者: Clifford B Saper.
来源: N Engl J Med. 2025年392卷19期1968-1971页

368. Progress toward Mitigating Disability Progression in Multiple Sclerosis.

作者: Peter A Calabresi.
来源: N Engl J Med. 2025年392卷19期1966-1968页

369. Case 14-2025: A 29-Year-Old Woman with Peritonsillar Swelling and Bleeding.

作者: Rahmatullah Wais Rahmati.;Katherine L Reinshagen.;Rosh K V Sethi.;David S Shulman.;Emily M Hartsough.
来源: N Engl J Med. 2025年392卷19期1954-1964页

370. Plight on the Pickleball Court.

作者: Catherina X Pan.;Anand Vaidya.;Daniel P Marcusa.;Jacob A Burns.;Thomas Michel.
来源: N Engl J Med. 2025年392卷19期e46页

371. Torsion of a Mature Cystic Ovarian Teratoma.

作者: Xiaodong Zhang.;Peng Xie.
来源: N Engl J Med. 2025年392卷19期e45页

372. Hair Tourniquet.

作者: Anton Ivan Moorees.;Dirk Vervloessem.
来源: N Engl J Med. 2025年392卷19期e44页

373. Ph-Positive Acute Lymphoblastic Leukemia - 25 Years of Progress.

作者: Robin Foà.
来源: N Engl J Med. 2025年392卷19期1941-1952页

374. Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.

作者: Victor Musiime.;Mutsa Bwakura-Dangarembizi.;Alexander J Szubert.;Vivian Mumbiro.;Hilda A Mujuru.;Cissy M Kityo.;Abbas Lugemwa.;Katja Doerholt.;Chishala Chabala.;Shafic Makumbi.;Veronica Mulenga.;Helen McIlleron.;David Burger.;Eva Natukunda.;Clare Shakeshaft.;Kyomuhendo Jovia Linda.;Kusum Nathoo.;Lara Monkiewicz.;Ibrahim Yawe.;Monica Kapasa.;Mary Nyathi.;Joyce Lungu.;Bwendo Nduna.;Wedu Ndebele.;Annabelle South.;Mwate Mwamabazi.;Godfrey Musoro.;Anna Griffiths.;Khozya Zyambo.;Rashidah Nazzinda.;Kevin Zimba.;Yingying Zhang.;Simon Walker.;Anna Turkova.;A Sarah Walker.;Alasdair Bamford.;Diana M Gibb.; .
来源: N Engl J Med. 2025年392卷19期1917-1932页

Children living with human immunodeficiency virus (HIV) have limited options for second-line antiretroviral therapy (ART).

375. Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1.

作者: Yves Dauvilliers.;Giuseppe Plazzi.;Emmanuel Mignot.;Gert Jan Lammers.;Rafael Del Río Villegas.;Ramin Khatami.;Mitsutaka Taniguchi.;Anson Abraham.;Yaming Hang.;Harisha Kadali.;Marta Lamberton.;Sarah Sheikh.;Ellie Stukalin.;Rachel Neuwirth.;Todd J Swick.;Shinichiro Tanaka.;Christian von Hehn.;Philipp von Rosenstiel.;Hao Wang.;Alice Cai.;Melissa Naylor.;Tina Olsson.
来源: N Engl J Med. 2025年392卷19期1905-1916页

Narcolepsy type 1 is a disorder of hypersomnolence caused by a loss of orexin neurons, which results in low orexin levels in the brain.

376. Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.

作者: Eric T Roberts.;Jessica Phelan.;Aaron L Schwartz.;Ellen Meara.;Dominic Ruggiero.;Lilly Estenson.;Rachel M Werner.;José F Figueroa.
来源: N Engl J Med. 2025年392卷20期2025-2034页

A total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality.

377. Paget's Disease of Bone.

作者: Masashi Hasebe.;Akihiro Hamasaki.
来源: N Engl J Med. 2025年392卷19期1953页

378. AI-Driven Clinical Documentation - Driving Out the Chitchat?

作者: Gordon D Schiff.
来源: N Engl J Med. 2025年392卷19期1877-1879页

379. Driving Jackson.

作者: Rajeev Raghavan.
来源: N Engl J Med. 2025年392卷19期1879-1881页

380. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

作者: Louis J Aronne.;Deborah Bade Horn.;Carel W le Roux.;Wayne Ho.;Beverly L Falcon.;Elisa Gomez Valderas.;Sagar Das.;Clare J Lee.;Leonard C Glass.;Cagri Senyucel.;Julia P Dunn.; .
来源: N Engl J Med. 2025年393卷1期26-36页

Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 diabetes is unknown.

结果排序

文献格式

出版时间

出版类型

出版语言